Johnson & Johnson (NYSE:JNJ) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $7.12-7.22 for the period, compared to the Thomson Reuters consensus estimate of $7.11. The company issued revenue guidance of $75.8-76.1 billion, compared to the consensus revenue estimate of $75.65 billion.

Several analysts recently issued reports on the company. UBS AG reiterated a buy rating and issued a $136.00 price target on shares of Johnson & Johnson in a report on Monday, May 15th. Vetr upgraded Johnson & Johnson from a hold rating to a buy rating and set a $132.33 price target for the company in a report on Thursday, May 18th. Stifel Nicolaus reiterated a hold rating and issued a $128.00 price target (up from $124.00) on shares of Johnson & Johnson in a report on Thursday, May 18th. BidaskClub upgraded Johnson & Johnson from a buy rating to a strong-buy rating in a report on Saturday, June 17th. Finally, Wells Fargo & Company reiterated a market perform rating and issued a $135.00 price target (up from $132.00) on shares of Johnson & Johnson in a report on Thursday, July 6th. Eleven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus target price of $133.65.

Shares of Johnson & Johnson (NYSE:JNJ) opened at 132.15 on Tuesday. The stock’s 50 day moving average price is $130.42 and its 200-day moving average price is $122.68. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $137.00. The company has a market cap of $355.99 billion, a PE ratio of 22.21 and a beta of 0.78.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 EPS for the quarter, beating the Zacks’ consensus estimate of $1.79 by $0.04. The firm had revenue of $18.84 billion for the quarter, compared to analyst estimates of $18.94 billion. Johnson & Johnson had a net margin of 22.87% and a return on equity of 26.50%. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.74 earnings per share. On average, equities research analysts forecast that Johnson & Johnson will post $7.10 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th will be given a $0.84 dividend. The ex-dividend date is Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.54%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 56.47%.

TRADEMARK VIOLATION NOTICE: “Johnson & Johnson (JNJ) Issues FY17 Earnings Guidance” was posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Earnings History and Estimates for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with's FREE daily email newsletter.